Founders Grove Wealth Partners’s Vanguard Health Care ETF VHT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.99M Sell
26,713
-408
-2% -$113K 1.59% 20
2026
Q1
$7.39M Buy
27,121
+1,412
+5% +$404K 1.68% 19
2025
Q4
$7.4M Sell
25,709
-51
-0.2% -$14.2K 1.66% 20
2025
Q3
$6.69M Buy
25,760
+90
+0.4% +$22.6K 1.57% 22
2025
Q2
$6.37M Buy
25,670
+1,174
+5% +$290K 1.6% 20
2025
Q1
$6.48M Buy
24,496
+1,628
+7% +$434K 1.81% 17
2024
Q4
$5.8M Buy
+22,868
New +$6.16M 1.68% 19

Other funds holding VHT

Founders Grove Wealth Partners's VHT Position: Q2 2026 in Review

Founders Grove Wealth Partners reduced its Vanguard Health Care ETF (VHT) stake by 1.5% in Q2 2026, selling an estimated $113K and leaving 26,713 shares worth $7.99M. The position accounts for 1.59% of the portfolio, ranked #20.

Founders Grove Wealth Partners first reported a position in VHT in Q4 2024 and has held it in 7 quarters since. 1,116 funds tracked by Wall St. Rank hold VHT as of Q2 2026.

  • Founders Grove Wealth Partners held 26,713 shares of Vanguard Health Care ETF worth $7.99M as of Q2 2026.
  • Founders Grove Wealth Partners sold 408 Vanguard Health Care ETF shares in Q2 2026, an estimated $113K.
  • Vanguard Health Care ETF made up 1.59% of Founders Grove Wealth Partners's portfolio in Q2 2026, its #20 holding.
  • Founders Grove Wealth Partners first reported a position in Vanguard Health Care ETF in Q4 2024 and has held it in 7 quarters since.
  • 1,116 funds tracked by Wall St. Rank held Vanguard Health Care ETF as of Q2 2026.

Based on Founders Grove Wealth Partners's 13F filing for Q2 2026, filed 22 Jul 2026.